Successful treatment of herpetic infections by autohemotherapy.

Rush Presbyterian St. Luke's Medical Center, Chicago, IL, USA.
The Journal of Alternative and Complementary Medicine (Impact Factor: 1.52). 02/1997; 3(2):155-8. DOI: 10.1089/acm.1997.3.155
Source: PubMed

ABSTRACT Herpes zoster (shingles) affects a significant number of individuals over age 50. To date, no satisfactory treatment has been available. The clinician author (JHO) witnessed a dramatic response of a shingles patient to autohemotherapy: the pain was completely relieved and lesions gone within 5 days with no recurrence of either. Treatment of other herpetic patients then began with autohemotherapy. Twenty-five patients with herpes were given an autologous blood transfer of 10 mL of blood from the antecubital vein into the gluteal bundle and followed for clinical signs. A 100% favorable response occurred in 20 patients who received autohemotherapy within 7 weeks of the onset of clinical signs and 1 other who received autohemotherapy at a 9-week interval. No untoward signs or symptoms of the treatment occurred. Autohemotherapy has been demonstrated to be effective in elimination of clinical sequelae in these cases of herpes infections and these results justify further rigorous clinical investigation.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Pruritic urticarial papules and plaques of pregnancy (PUPPP), also known as polymorphic eruption of pregnancy, is a common and benign but exceedingly uncomfortable dermatosis of pregnancy. Investigation of new treatment options has been limited by patient concerns about the negative fetal effects of medication. Objective To assess the efficacy of intramuscular injection of autologous whole blood (AWB) for treatment of PUPPP. Methods This is a retrospective descriptive case series of three patients with PUPPP, all of whom were treated with intramuscular injection of AWB. ResultsAll patients showed good responses to intramuscular injection of AWB, tolerated the treatment, and there were no adverse effects to the patients or their babies. ConclusionAWB may be an alternative treatment option for patients with PUPPP who are worried about the risk of medication use during pregnancy or breastfeeding. Whole blood collected from the patient's own body may be preferable to foreign medications. Future investigation into the exact mechanism with controlled clinical studies using a large number of patients will be necessary to provide supporting evidence for this potential treatment.
    Journal of the European Academy of Dermatology and Venereology 02/2014; DOI:10.1111/jdv.12414 · 3.11 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Ozone, a naturally occurring configuration of three oxygen atoms best known for its protective role in the earth's ecological harmony, possesses unique properties which are being defined and applied to biological systems as well as to clinical practice. As a molecule containing a large excess of energy, ozone manifests bactericidal, virucidal and fungicidal actions that may make it a treatment of choice in certain conditions and an adjunctive treatment in others.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Chronic urticaria (CU) is a vexing problem and patients of CU suffer from the morbidity that arise from irritable itch and weals and are also subjected to a huge antihistamine pill burden. The symptoms are more in autoreactive urticaria (AU) where auto‑antibodies in blood flares‑up the condition. Search for newer effective modalities which can reduce pill burden is a felt need. Aims: This study evaluates the effectiveness of autologous serum therapy (AST) in CU and also determines its usefulness in AU. Materials and Methods: Double blind, parallel group, randomized, controlled study. Fifty four patients were given AST and 57 patients were given injection normal saline (placebo), along with cetirizine in an on‑demand basis in both groups. AST/Placebo was given weekly for nine weeks and followed‑up for a total period of 24 weeks. AU was diagnosed by autologous serum skin test. Urticaria total severity score (TSS), Urticaria activity score (UAS), Dermatologic life quality index (DLQI) was used as primary effectiveness variables. Safety parameters assessed were the spontaneously reported adverse events and laboratory parameters. Results: TSS showed significant improvement from baseline, 7th week and 8th week onwards in AST group and placebo group respectively. Group comparison showed significant improvement 4th week onwards. UAS showed similar results. DLQI showed significant improvement in AST group compared to placebo at the end of study. Both AU and non‑AU patients showed comparable improvement of TSS. Conclusion: AST shows promise in treatment of urticaria regardless of the autoreactive nature.
    Indian Journal of Dermatology 01/2014; 59:375-82. DOI:10.4103/0019-5154.135490